CD69 and COVID-19: There were reduced frequency and an activated phenotype of circulating MAIT cells in COVID-19 patients regardless of disease severity, as demonstrated by high levels of IL-17A, TNF-α, CD38, CD69, and HLA-DR expression (Deschler et al., 2021).